Stocks › Biotechnology › DNA

Ginkgo Bioworks DNA

US equityMarket cap rank #3432Biotechnology AI medical concept stocks

$11.47 −$0.94 (-7.57%)

Pre-market · Oct 8, 8:20 am ET · After hours $11.31 -1.40%

Open$11.81

Prev close$12.41

Day range$10.81 – $11.95

Volume6.46M

Market cap$772.39M

P/E (TTM)–

Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership59.1%-6.99 pts vs. prior quarter

Institutions holding216-3 vs. prior quarter

Insider trades (recent)18 buys / 32 sellsNet selling

Short interest10.64% of floatDays to cover 7.2 · as of 15 Sep 2026

Short-sale volume share18.6%5-day average of daily volume

Short-sale volume as % of daily volume

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$2.15M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 24.1% of shares outstanding.

Largest holders

BlackRock6.36%
Viking Global Investors LP5.31%
Cascade Investment, L.L.C.4.93%
Erste Asset Management GmbH3.77%
Reshma Shetty3.69%
Vanguard Capital Management, LLC3.56%
Baillie Gifford3.55%
Austin Che3.54%

By investor type

Mutual Fund35.57%
Individual/Insider14.96%
Hedge Fund13.85%
Family Office/Trust4.95%
Public Company2.29%
VC/PE Fund1.13%
Private Company0.79%
Insurance Company0.31%

Reported short interest has risen from 7.90% to 10.64% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

Holder	Type	Period	Share change	New stake
Nuveen Asset Management LLC	Insurance Company	2026/Q3	+140,485	0.2%
BlackRock	Mutual Fund	2026/Q3	+640,556	6.4%
Erste Asset Management GmbH	Mutual Fund	2026/Q3	+589,211	3.8%
Renaissance Technologies Corp.	Hedge Fund	2026/Q3	+439,400	0.8%
Vanguard Portfolio Management, LLC	Mutual Fund	2026/Q3	+372,151	1.4%
AQR Capital Management	Hedge Fund	2026/Q3	+327,492	0.9%
Acadian Asset Management LLC	Mutual Fund	2026/Q3	+243,102	0.4%
Dimensional Fund Advisors	Mutual Fund	2026/Q3	+224,152	0.5%
Geode Capital Management, LLC	Mutual Fund	2026/Q3	+212,654	1.8%
Vanguard Capital Management, LLC	Mutual Fund	2026/Q3	+210,699	3.6%
Balance Capital Partners L.P.	Hedge Fund	2026/Q3	+199,009	0.3%
Millennium Management LLC	Hedge Fund	2026/Q3	+150,719	0.9%
Citadel Advisors LLC	Hedge Fund	2026/Q3	+130,935	0.2%
State Street Global Advisors	Mutual Fund	2026/Q3	+125,711	2.2%
D. E. Shaw & Co., L.P.	Hedge Fund	2026/Q3	+124,187	0.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

Date	Insider	Title	Transaction	Shares	Price	Held after
4 Oct 2026	Steven Coen	Chief Accounting Officer	Intent to Sell (Form 144)	-2,403	$15.00	–
16 Sep 2026	Austin Che	Founder, Head of Strategy & Treasurer	Intent to Sell (Form 144)	-2,200	$7.29	–
14 Sep 2026	Christian O. Henry	Independent Director	Open Market Disposition	-5,000	$7.08	19,310
23 Aug 2026	Steven Coen	Chief Accounting Officer	Intent to Sell (Form 144)	-330	$6.98	–
23 Aug 2026	Steven Coen	Chief Accounting Officer	Derivative Exercise and Sale	-330	$6.98	51,851
20 Aug 2026	Steven Coen	Chief Accounting Officer	Derivative Exercise and Retained	+413	–	51,851
16 Aug 2026	Austin Che	Founder, Head of Strategy & Treasurer	Intent to Sell (Form 144)	-2,200	$6.66	–
27 Jul 2026	Jason Kelly	Chief Executive Officer	Other Derivative Acquisition	+383,725	–	309,467
27 Jul 2026	Reshma Shetty	Founder, President, COO & Director	Other Derivative Acquisition	+319,332	–	117,135
27 Jul 2026	Bartholomew Canton	Founder, CTO & Secretary	Other Derivative Acquisition	+319,332	–	127,423
16 Jul 2026	Steven Coen	Chief Accounting Officer	Intent to Sell (Form 144)	-752	$7.90	–
16 Jul 2026	Steven Coen	Chief Accounting Officer	Derivative Exercise and Sale	-752	$7.90	51,438
15 Jul 2026	Steven Coen	Chief Accounting Officer	Derivative Exercise and Retained	+734	–	51,438
10 Jun 2026	Harry Sloan	Independent Director	Other Derivative Acquisition	+25,000	–	25,000
10 Jun 2026	Christian O. Henry	Independent Director	Other Derivative Acquisition	+25,000	–	25,000
10 Jun 2026	Ross Fubini	Independent Director	Other Derivative Acquisition	+25,000	–	25,000
10 Jun 2026	Sriram Kosuri	Director	Other Derivative Acquisition	+25,000	–	25,000
9 Jun 2026	Austin Che	Founder, Head of Strategy & Treasurer	Intent to Sell (Form 144)	-2,200	$8.06	–
21 May 2026	Steven Coen	Chief Accounting Officer	Intent to Sell (Form 144)	-307	$8.33	–
21 May 2026	Steven Coen	Chief Accounting Officer	Derivative Exercise and Sale	-307	$8.33	50,704

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report date	Shares short	% of float	Days to cover
15 Sep 2026	7,166,128	10.6%	7.2
31 Aug 2026	6,865,017	10.2%	5.5
14 Aug 2026	5,596,447	8.3%	4.3
31 Jul 2026	5,317,028	8.1%	6.7
15 Jul 2026	5,208,417	8.0%	5.0
30 Jun 2026	5,160,266	7.9%	4.0

Discussion

No comments yet — be the first to weigh in on DNA.